Stock A266470 BIOINFRA LIFE SCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company BioInfra Life Science Inc.

Equities

A266470

KR7266470004

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 03/07/2024 am IST 		5-day change 1st Jan Change
314 KRW -9.77% Intraday chart for BioInfra Life Science Inc. -0.63% -13.97%
2021 BioInfra Life Science Inc. announced that it has received KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd. CI
2021 BioInfra Life Science Inc. announced that it has received KRW 1.999998 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd. CI

Business Summary

BioInfra Life Science Inc is a Korea-based company mainly engaged in the research and development and manufacture of protein chip contents. The Company provides diagnostic testing services and research services. The Company provides services such as multi-biomarker blood tests, diagnosis kit development, biomarker discovery, and peptide chip development.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Service
74.5 %
1,175 78.7 % 969 74.5 % -17.52%
Research
21.1 %
275 18.4 % 274 21.1 % -0.19%
Protein Chips
4.5 %
42 2.8 % 58 4.5 % +37.31%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
80.7 %
1,245 83.4 % 1,050 80.7 % -15.66%
Overseas
19.3 %
247 16.6 % 252 19.3 % +1.77%

Managers

Managers TitleAgeSince
Duk-Yoon Lee CEO
 Chief Executive Officer 61 -
Chul-Woo Kim CTO
 Chief Tech/Sci/R&D Officer 72 -
Tae-Kyum Kim AUD
 Comptroller/Controller/Auditor 72 -

Members of the board

Members of the board TitleAgeSince
Mahn-Soon Hwang BRD
 Director/Board Member 54 -
Wook Ahn BRD
 Director/Board Member 48 -
Chul-Woo Kim CTO
 Chief Tech/Sci/R&D Officer 72 -
Duk-Yoon Lee CEO
 Chief Executive Officer 61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 818,179 0 0 74.73 %
Stock B 0 363,636 0 0
Stock C 1 14,106,847 10,541,380 ( 74.73 %) 0
Stock D 0 566,036 0 0

Company contact information

Bioinfra Life Science, Inc.

7F, SGI Building 49 Daehak-ro

03127, Seoul

+

http://www.bioinfra.co.kr
address BioInfra Life Science Inc.(A266470)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BIOINFRA LIFE SCIENCE INC. Stock BioInfra Life Science Inc.
-13.97% 3.54M
MODERNA, INC. Stock Moderna, Inc.
+16.59% 44.87B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-10.62% 37.8B
LONZA GROUP AG Stock Lonza Group AG
+40.49% 37.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+29.92% 31.32B
CELLTRION, INC. Stock Celltrion, Inc.
-9.78% 27.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.34% 26.32B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+41.53% 14.07B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.49% 12.5B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.40% 11.23B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A266470 Stock
  4. Company BioInfra Life Science Inc.